Showing results (11-20 of 731) with videos related to
Sort By:
Pageof 74
Oncoimmunology|July 21, 2022
Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent responseChuan Jin, Arwa Ali, Alexandros Iskantar, et al.Oncoimmunology|February 6, 2018
Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma modelsGrammatiki Fotaki, Chuan Jin, Iliana Kyriaki Kerzeli, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2013
An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumorsMohanraj Ramachandran, Di Yu, Alkwin Wanders, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A hexon and fiber-modified adenovirus expressing CD40L improves the antigen presentation capacity of dendritic cellsLina Liljenfeldt, Di Yu, Liye Chen, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 11, 2015
Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancerVictoria Hillerdal, Magnus EssandCancer Immunology, Immunotherapy : CII|July 12, 2025
Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomasJing Ma, Tina Sarén, Chuan Jin, et al.Neuroendocrinology|July 22, 2016
Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine CancerDi Yu, Justyna Leja-Jarblad, Angelica Loskog, et al.Trends in Immunology|August 15, 2025
News from the T cell trogocytosis frontStefano Barbera, Anna Dimberg, Magnus EssandPageof 74